CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence-Reference-Cited by-同舟云学术

CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence

Published:2023-11 Issue:22 Volume:83 Page:4062-4077.e5
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Crozier Lisa,Foy Reece,Adib Rozita,Kar Ananya,Holt Jordan A.,Pareri Aanchal U.,Valverde Juan M.,Rivera Rene,Weston William A.,Wilson Rona,Regnault Clement,Whitfield Phil,Badonyi Mihaly,Bennett Laura G.,Vernon Ellen G.,Gamble Amelia,Marsh Joseph A.,Staples Christopher J.,Saurin Adrian T.,Barr Alexis R.,Ly Tony^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference78 articles.

1. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

2. Overall survival with Ribociclib plus endocrine therapy in breast cancer;Im;N. Engl. J. Med.,2019

3. MONARCH 1, A Phase II study of Abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2− metastatic breast cancer;Dickler;Clin. Cancer Res.,2017

4. Mechanisms of sensitivity and resistance to CDK4/6 inhibition;Álvarez-Fernández;Cancer Cell,2020

5. Cell cycle control in cancer;Matthews;Nat. Rev. Mol. Cell Biol.,2022

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTOR potentiates senescent phenotypes and primary cilia formation after cisplatin-induced G2 arrest in retinal pigment epithelial cells;Cellular Signalling;2024-12

2. Eukaryotic cell size regulation and its implications for cellular function and dysfunction;Physiological Reviews;2024-10-01

3. An unscheduled switch to endocycles induces a reversible senescent arrest that impairs growth of the Drosophila wing disc;PLOS Genetics;2024-09-03

4. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

5. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes;Clinical and Translational Medicine;2024-09